-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It is now widely accepted that oligosaccharides, covalently linked to proteins, can modulate both the physicochemical andbiological properties of glycoproteins (
1
–
3
). Thus glycans can play a number of important roles: they can ensure that a protein is correctly folded; they can stabilizea particular conformation of a glycoprotein; they can prevent protein aggregation; and they can protect a protein from proteaseactivity. Some of the biological roles of oligosaccharides include participation in cell-cell adhesion and immunological andreproduction processes (
4
,
5
). The clinical efficacy of a therapeutic glycoprotein may also be affected by the nature of its carbohydrate. Therefore itis important to minimize carbohydrate content from one batch to another, as this may lead to variations in solubility, metabolism,pharmacokinetics, and ultimately functional activity. Engineering of oligosaccharide structures in therapeutic glycoproteinscan be useful in tailoring their desirable efficacy.